Key regions: United Kingdom, Canada, Japan, Europe, China
The demand for dermatological drugs in Kazakhstan has been on the rise in recent years.
Customer preferences: Customers in Kazakhstan have shown a growing interest in dermatological drugs due to the increasing prevalence of skin diseases in the country. Skin conditions such as acne, eczema, and psoriasis are becoming more common, leading to a higher demand for medications to treat these conditions. Additionally, the growing awareness of the importance of skincare and the availability of a wider range of products have contributed to the growth of the dermatological drugs market in Kazakhstan.
Trends in the market: One of the major trends in the dermatological drugs market in Kazakhstan is the increasing popularity of topical medications. These medications are preferred by customers due to their ease of use and effectiveness in treating various skin conditions. Another trend is the growing demand for natural and organic skincare products. Customers are becoming more conscious of the ingredients in their skincare products and are opting for products that are free from harmful chemicals.
Local special circumstances: Kazakhstan has a harsh climate, with extreme temperatures and dry air, which can cause skin problems such as dryness and sensitivity. This has led to a higher demand for moisturizers and other skincare products that can help to hydrate and protect the skin. Additionally, Kazakhstan has a large Muslim population, and there is a growing demand for halal-certified skincare products.
Underlying macroeconomic factors: Kazakhstan has been experiencing steady economic growth in recent years, which has led to an increase in disposable income and consumer spending. This has contributed to the growth of the dermatological drugs market, as customers are able to afford more expensive and high-quality skincare products. Additionally, the government has been investing in the healthcare sector, which has led to an improvement in healthcare facilities and services, including dermatological care.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
